Richard Becker, MD
Radiology & Biomedical Imaging
Biography
Richard Becker, MD, is a neuoradiologist specializing in radiology and biomedical imaging. He uses medical imaging techniques to diagnose and monitor a wide range of conditions, offering patients insights into their health using technologies such as X-ray, MRI, and CT scans.
At Yale School of Medicine, Dr. Becker is involved in radiology-related research, working on techniques to enhance diagnostic accuracy and patient outcomes.
He received his medical degree from New York Medical College.
Titles
- Staff Affiliate - Other
Education & Training
- FellowshipNew York Hospital - Cornell Medical Center (1986)
- ResidencyMontefiore Medical Center (1984)
- InternshipMontefiore Medical Center (1981)
- MDNew York Medical College (1979)
Additional Information
Board Certifications
- AB of Radiology, Diagnostic Radiology (1984)
Publications
- Du W, Ringer M, Huang W, Desai D, Khandakar G, Tron Esqueda L, Wang C, Guan J, Becker R, Sadayappan S, Fan G, Wang Y, Fan Y. Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction. Circulation 2025 PMID: 41410033, DOI: 10.1161/circulationaha.124.071774.
- Becker R. Discernment and Finding Joy in Medicine: Commentary. The American Journal Of Medicine 2025 PMID: 41177425, DOI: 10.1016/j.amjmed.2025.10.031.
- Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M, Flynn J, Hanevold C, Hooper S, Ingelfinger J, Lande M, Martin L, Meyers K, Mitsnefes M, Rosner B, Samuels J, Kuffel G, Zilliox M, Chen Q, Becker R, Urbina E, Sadayappan S. A Multiomics Approach to Defining Target‐Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort. Journal Of The American Heart Association 2025, 14: e037649. PMID: 41147417, PMCID: PMC12684800, DOI: 10.1161/jaha.124.037649.
- Becker R. Healthcare in the United States: politics, policy, and potential global impact. Journal Of Thrombosis And Thrombolysis 2025, 1-11. PMID: 41099930, DOI: 10.1007/s11239-025-03190-3.
- Abu-Nejim H, Becker R. Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation. Current Atherosclerosis Reports 2025, 27: 99. PMID: 41065947, PMCID: PMC12511252, DOI: 10.1007/s11883-025-01350-7.
- Becker R. Immune checkpoint inhibitors and cardiovascular toxicity: immunology, pathophysiology, diagnosis, and management. Journal Of Thrombosis And Thrombolysis 2025, 58: 1021-1044. PMID: 40673965, PMCID: PMC12740968, DOI: 10.1007/s11239-025-03146-7.
- Andersen T, Ueland T, Lakic T, Åkerblom A, Bertilsson M, Aukrust P, Michelsen A, James S, Becker R, Storey R, Wallentin L, Siegbahn A, Kontny F, Investigators F. Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arteriosclerosis Thrombosis And Vascular Biology 2025, 45: e336-e336. PMID: 40560990, DOI: 10.1161/atv.0000000000000187.
- Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M, Flynn J, Hanevold C, Hooper S, Ingelfinger J, Lande M, Martin L, Meyers K, Mitsnefes M, Rosner B, Samuels J, Kuffel G, Zilliox M, Becker R, Urbina E, Sadayappan S. A Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension. Journal Of Molecular And Cellular Cardiology Plus 2025, 12: 100339. DOI: 10.1016/j.jmccpl.2025.100339.
- Khan M, Becker R. Bridging the gap: strategies for recognizing and managing post-COVID conditions. Frontiers In Medicine 2024, 11: 1395420. PMID: 39635598, PMCID: PMC11615723, DOI: 10.3389/fmed.2024.1395420.
- Becker R, Harnett B, Wayne D, Mardis R, Meganathan K, Steen D. PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study. Clinical Research In Cardiology 2024, 114: 497-506. PMID: 39527276, DOI: 10.1007/s00392-024-02572-6.
- Hooper S, Lande M, Flynn J, Hanevold C, Meyers K, Samuels J, Becker R, Daniels S, Falkner B, Ferguson M, Ingelfinger J, Martin L, Mitsnefes M, Khoury P, Seo J, Urbina E. Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension 2024, 81: 2444-2453. PMID: 39291378, PMCID: PMC11578784, DOI: 10.1161/hypertensionaha.124.22834.
- Becker R, Tantry U, Khan M, Gurbel P. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management. Journal Of Thrombosis And Thrombolysis 2024, 58: 15-49. PMID: 39179952, PMCID: PMC11762605, DOI: 10.1007/s11239-024-03028-4.
- Becker R. The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting. Journal Of Thrombosis And Thrombolysis 2024, 57: 1103-1108. PMID: 38980568, DOI: 10.1007/s11239-024-03012-y.
- Tantry U, Raghavakurup L, Becker R, Singh S, Bliden K, Gurbel P. Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome. Expert Opinion On Pharmacotherapy 2024, 25: 1271-1280. PMID: 39072402, DOI: 10.1080/14656566.2024.2385062.
- Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, 13: e028951. PMID: 38780169, PMCID: PMC11255646, DOI: 10.1161/jaha.122.028951.
- Ali A, Becker R. The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease. Journal Of Thrombosis And Thrombolysis 2024, 57: 1283-1296. PMID: 38662114, PMCID: PMC11645312, DOI: 10.1007/s11239-024-02985-0.
- Ali A, Becker R. Factor XI: structure, function and therapeutic inhibition. Journal Of Thrombosis And Thrombolysis 2024, 57: 1315-1328. PMID: 38622277, PMCID: PMC11645426, DOI: 10.1007/s11239-024-02972-5.
- Eggers K, Batra G, Lindahl B, Lakic T, Lindbäck J, Budaj A, Cornel J, Giannitsis E, Katus H, Storey R, Becker R, Siegbahn A, Wallentin L. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry And Laboratory Medicine 2024, 62: 1167-1176. PMID: 38341860, DOI: 10.1515/cclm-2023-1253.
- Becker R. Evaluating chest pain in patients with post COVID conditions permission to think outside of the box. Journal Of Thrombosis And Thrombolysis 2023, 55: 592-603. PMID: 37052772, PMCID: PMC10098243, DOI: 10.1007/s11239-023-02808-8.
- Thomas M, James S, Becker R, Himmelmann A, Katus H, Cannon C, Steg P, Siegbahn A, Lakic T, Storey R, Wallentin L. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. European Heart Journal Acute Cardiovascular Care 2019 PMID: 33609104, DOI: 10.1177/2048872619878075.
- Jennings L, Moliterno D, Storey R, Hord E, Kotha J, Becker R, Smyth S, Providencia L, Moccetti T, Valgimigli M, Dery J, Cornel J, Thomas G, Huber K, Chen E, Strony J, Rorick T, Tricoci P, Mahaffey K. PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL. Journal Of The American College Of Cardiology 2012, 59: e351. DOI: 10.1016/s0735-1097(12)60352-0.
- Cornel J, Becker R, Goodman S, Husted S, Katus H, Santoso A, Steg P, Storey R, Vintila M, sun J, Horrow J, Wallentin L, Harrington R, James S. PRIOR SMOKING STATUS, CLINICAL OUTCOMES, AND THE COMPARISON OF TICAGRELOR WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROMES – INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal Of The American College Of Cardiology 2012, 59: e495. DOI: 10.1016/s0735-1097(12)60496-3.
- Becker R, Alpert J. Vasopressin Therapy of Hemorrhagic Complications Following Coronary Artery Bypass Grafting-Reply. JAMA Internal Medicine 1991, 151: 2100-2100. DOI: 10.1001/archinte.1991.00400100150029.
- The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass GraftingBecker R, Alpert J. The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass Grafting. JAMA Internal Medicine 1990, 150: 2016-2021. PMID: 2222086, DOI: 10.1001/archinte.1990.00390210018006.
- Becker R, Alpert J. Electrocardiographic ST segment depression in coronary heart disease. American Heart Journal 1988, 115: 862-868. PMID: 3354415, DOI: 10.1016/0002-8703(88)90890-3.
- Nocturnal diaphoresis and coronary artery spasm. Contribution of the parasympathetic nervous system.Becker R, Giuliani M, Alpert J. Nocturnal diaphoresis and coronary artery spasm. Contribution of the parasympathetic nervous system. Cleveland Clinic Journal Of Medicine 1987, 54: 515-8. PMID: 3690824, DOI: 10.3949/ccjm.54.6.515.
- BECKER R, ALPERT J. Nocturnal diaphoresis in Prinzmetal angina. Annals Of Internal Medicine 1987, 107: 121. PMID: 3592439, DOI: 10.7326/0003-4819-107-1-121_1.
Departments and Programs
Biography
Richard Becker, MD, is a neuoradiologist specializing in radiology and biomedical imaging. He uses medical imaging techniques to diagnose and monitor a wide range of conditions, offering patients insights into their health using technologies such as X-ray, MRI, and CT scans.
At Yale School of Medicine, Dr. Becker is involved in radiology-related research, working on techniques to enhance diagnostic accuracy and patient outcomes.
He received his medical degree from New York Medical College.
Titles
- Staff Affiliate - Other
Education & Training
- FellowshipNew York Hospital - Cornell Medical Center (1986)
- ResidencyMontefiore Medical Center (1984)
- InternshipMontefiore Medical Center (1981)
- MDNew York Medical College (1979)
Additional Information
Board Certifications
- AB of Radiology, Diagnostic Radiology (1984)
Publications
- Du W, Ringer M, Huang W, Desai D, Khandakar G, Tron Esqueda L, Wang C, Guan J, Becker R, Sadayappan S, Fan G, Wang Y, Fan Y. Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction. Circulation 2025 PMID: 41410033, DOI: 10.1161/circulationaha.124.071774.
- Becker R. Discernment and Finding Joy in Medicine: Commentary. The American Journal Of Medicine 2025 PMID: 41177425, DOI: 10.1016/j.amjmed.2025.10.031.
- Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M, Flynn J, Hanevold C, Hooper S, Ingelfinger J, Lande M, Martin L, Meyers K, Mitsnefes M, Rosner B, Samuels J, Kuffel G, Zilliox M, Chen Q, Becker R, Urbina E, Sadayappan S. A Multiomics Approach to Defining Target‐Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort. Journal Of The American Heart Association 2025, 14: e037649. PMID: 41147417, PMCID: PMC12684800, DOI: 10.1161/jaha.124.037649.
- Becker R. Healthcare in the United States: politics, policy, and potential global impact. Journal Of Thrombosis And Thrombolysis 2025, 1-11. PMID: 41099930, DOI: 10.1007/s11239-025-03190-3.
- Abu-Nejim H, Becker R. Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation. Current Atherosclerosis Reports 2025, 27: 99. PMID: 41065947, PMCID: PMC12511252, DOI: 10.1007/s11883-025-01350-7.
- Becker R. Immune checkpoint inhibitors and cardiovascular toxicity: immunology, pathophysiology, diagnosis, and management. Journal Of Thrombosis And Thrombolysis 2025, 58: 1021-1044. PMID: 40673965, PMCID: PMC12740968, DOI: 10.1007/s11239-025-03146-7.
- Andersen T, Ueland T, Lakic T, Åkerblom A, Bertilsson M, Aukrust P, Michelsen A, James S, Becker R, Storey R, Wallentin L, Siegbahn A, Kontny F, Investigators F. Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arteriosclerosis Thrombosis And Vascular Biology 2025, 45: e336-e336. PMID: 40560990, DOI: 10.1161/atv.0000000000000187.
- Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M, Flynn J, Hanevold C, Hooper S, Ingelfinger J, Lande M, Martin L, Meyers K, Mitsnefes M, Rosner B, Samuels J, Kuffel G, Zilliox M, Becker R, Urbina E, Sadayappan S. A Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension. Journal Of Molecular And Cellular Cardiology Plus 2025, 12: 100339. DOI: 10.1016/j.jmccpl.2025.100339.
- Khan M, Becker R. Bridging the gap: strategies for recognizing and managing post-COVID conditions. Frontiers In Medicine 2024, 11: 1395420. PMID: 39635598, PMCID: PMC11615723, DOI: 10.3389/fmed.2024.1395420.
- Becker R, Harnett B, Wayne D, Mardis R, Meganathan K, Steen D. PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study. Clinical Research In Cardiology 2024, 114: 497-506. PMID: 39527276, DOI: 10.1007/s00392-024-02572-6.
- Hooper S, Lande M, Flynn J, Hanevold C, Meyers K, Samuels J, Becker R, Daniels S, Falkner B, Ferguson M, Ingelfinger J, Martin L, Mitsnefes M, Khoury P, Seo J, Urbina E. Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension 2024, 81: 2444-2453. PMID: 39291378, PMCID: PMC11578784, DOI: 10.1161/hypertensionaha.124.22834.
- Becker R, Tantry U, Khan M, Gurbel P. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management. Journal Of Thrombosis And Thrombolysis 2024, 58: 15-49. PMID: 39179952, PMCID: PMC11762605, DOI: 10.1007/s11239-024-03028-4.
- Becker R. The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting. Journal Of Thrombosis And Thrombolysis 2024, 57: 1103-1108. PMID: 38980568, DOI: 10.1007/s11239-024-03012-y.
- Tantry U, Raghavakurup L, Becker R, Singh S, Bliden K, Gurbel P. Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome. Expert Opinion On Pharmacotherapy 2024, 25: 1271-1280. PMID: 39072402, DOI: 10.1080/14656566.2024.2385062.
- Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, 13: e028951. PMID: 38780169, PMCID: PMC11255646, DOI: 10.1161/jaha.122.028951.
- Ali A, Becker R. The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease. Journal Of Thrombosis And Thrombolysis 2024, 57: 1283-1296. PMID: 38662114, PMCID: PMC11645312, DOI: 10.1007/s11239-024-02985-0.
- Ali A, Becker R. Factor XI: structure, function and therapeutic inhibition. Journal Of Thrombosis And Thrombolysis 2024, 57: 1315-1328. PMID: 38622277, PMCID: PMC11645426, DOI: 10.1007/s11239-024-02972-5.
- Eggers K, Batra G, Lindahl B, Lakic T, Lindbäck J, Budaj A, Cornel J, Giannitsis E, Katus H, Storey R, Becker R, Siegbahn A, Wallentin L. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry And Laboratory Medicine 2024, 62: 1167-1176. PMID: 38341860, DOI: 10.1515/cclm-2023-1253.
- Becker R. Evaluating chest pain in patients with post COVID conditions permission to think outside of the box. Journal Of Thrombosis And Thrombolysis 2023, 55: 592-603. PMID: 37052772, PMCID: PMC10098243, DOI: 10.1007/s11239-023-02808-8.
- Thomas M, James S, Becker R, Himmelmann A, Katus H, Cannon C, Steg P, Siegbahn A, Lakic T, Storey R, Wallentin L. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. European Heart Journal Acute Cardiovascular Care 2019 PMID: 33609104, DOI: 10.1177/2048872619878075.
- Jennings L, Moliterno D, Storey R, Hord E, Kotha J, Becker R, Smyth S, Providencia L, Moccetti T, Valgimigli M, Dery J, Cornel J, Thomas G, Huber K, Chen E, Strony J, Rorick T, Tricoci P, Mahaffey K. PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL. Journal Of The American College Of Cardiology 2012, 59: e351. DOI: 10.1016/s0735-1097(12)60352-0.
- Cornel J, Becker R, Goodman S, Husted S, Katus H, Santoso A, Steg P, Storey R, Vintila M, sun J, Horrow J, Wallentin L, Harrington R, James S. PRIOR SMOKING STATUS, CLINICAL OUTCOMES, AND THE COMPARISON OF TICAGRELOR WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROMES – INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal Of The American College Of Cardiology 2012, 59: e495. DOI: 10.1016/s0735-1097(12)60496-3.
- Becker R, Alpert J. Vasopressin Therapy of Hemorrhagic Complications Following Coronary Artery Bypass Grafting-Reply. JAMA Internal Medicine 1991, 151: 2100-2100. DOI: 10.1001/archinte.1991.00400100150029.
- The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass GraftingBecker R, Alpert J. The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass Grafting. JAMA Internal Medicine 1990, 150: 2016-2021. PMID: 2222086, DOI: 10.1001/archinte.1990.00390210018006.
- Becker R, Alpert J. Electrocardiographic ST segment depression in coronary heart disease. American Heart Journal 1988, 115: 862-868. PMID: 3354415, DOI: 10.1016/0002-8703(88)90890-3.
- Nocturnal diaphoresis and coronary artery spasm. Contribution of the parasympathetic nervous system.Becker R, Giuliani M, Alpert J. Nocturnal diaphoresis and coronary artery spasm. Contribution of the parasympathetic nervous system. Cleveland Clinic Journal Of Medicine 1987, 54: 515-8. PMID: 3690824, DOI: 10.3949/ccjm.54.6.515.
- BECKER R, ALPERT J. Nocturnal diaphoresis in Prinzmetal angina. Annals Of Internal Medicine 1987, 107: 121. PMID: 3592439, DOI: 10.7326/0003-4819-107-1-121_1.
Departments and Programs